Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 303 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Abdominal Hernia Clear all

Conditions: Ventral Hernia
Interventions: Fortiva™ Porcine Dermis, Strattice™ Reconstructive Tissue Matrix; Device
Lead sponsor: RTI Surgical; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Congenital Diaphragmatic Hernia
Interventions: BALT GOLDBAL2 Balloon; Device
Lead sponsor: Inna Lobeck; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Congenital Diaphragmatic Hernia
Interventions: Fetal Treatment arm (FETO Group); Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Herniorrhaphy, Postoperative Pain, Inguinal Hernia
Interventions: Bupivacaine Collagen Sponge, Placebo collagen Sponge; Drug
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Bellaire, Texas

Conditions: Inguinal Hernias
Interventions: Standard open tension-free inguinal hernia repair with mesh; Procedure
Lead sponsor: Creighton University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 720 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Diaphragmatic Hernia, Lung Disease
Interventions: Fetal tracheal obstruction with detachable balloon (device); Device
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Ventral Hernia, Incisional Hernia, Hernia, Hernia Abdominal Wall, Hernia Incisional, Hernia Incisional Ventral, Hernia of Abdominal Wall, Hernia Surgery
Interventions: Cryoneurolysis; Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral, Hernia Repair With Compartment Syndrome, Hernia Surgery, Hernia, Hernia Incisional
Interventions: OnabotulinumtoxinA Injection, Saline (placebo) Injection, OnabotulinumtoxinA, 0.9 % Normal Saline, Open Ventral Hernia Repair; Procedure · Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Inguinal Hernia
Interventions: TLC590, Naropin; Drug
Lead sponsor: Taiwan Liposome Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Draper, Utah

Conditions: Hernia, Ventral, Ileus
Interventions: Neostigmine / Glycopyrrolate, Sugammadex; Drug
Lead sponsor: Clayton Petro; Other
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Inguinal Hernia
Interventions: Not listed
Lead sponsor: United States Naval Medical Center, Portsmouth; Federal
Eligibility: 21 Years and older · Male only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Portsmouth, Virginia

Conditions: Pain, Inguinal Hernia
Interventions: TAP Block, Ilioinguinal/iliohypogastric blockade; Procedure
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 12 Months to 10 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Ventral Hernia, Adhesions
Interventions: Clinically-Indicated Abdominal Re-Exploration Surgery; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 6
States / cities: Phoenix, Arizona • San Diego, California • Springfield, Massachusetts + 3 more

Conditions: Hernia, Ventral
Interventions: Ventralight, Strattice; Device
Lead sponsor: Hobart Harris; Other
Eligibility: 21 Years and older
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hernia, DIaphragmatic, Congenital
Interventions: FETO therapy; Device
Lead sponsor: Children's Hospitals and Clinics of Minnesota; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Gastroesophageal Reflux Disease, Hiatal Hernia
Interventions: TIF Transoral Fundoplication, Sham placebo procedure; Device · Other
Lead sponsor: EndoGastric Solutions; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 9
States / cities: Los Angeles, California • Englewood, Colorado • Chicago, Illinois + 5 more

Conditions: Total Parenteral Nutrition-induced Cholestasis, Cholestasis, Short Bowel Syndrome, Gastroschisis, Intestinal Atresia, Infant, Premature, Diseases, Cholestasis of Parenteral Nutrition
Interventions: Omegaven; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: Up to 18 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Inguinal Hernia, Inguinal Hernia, Indirect, Inguinal Hernia Bilateral, Inguinal Hernia Unilateral
Interventions: Laryngeal Mask Airway, Endotracheal Tube Device; Device
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 12 Months to 8 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Congenital Diaphragmatic Hernia, Congenital Diaphragmatic Eventration, Congenital Hiatal Hernia, Congenital Diaphragmatic Disorders
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Not listed
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2021
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Hernia, Abdominal
Interventions: Port Close; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hernia, Hernia, Ventral, Pathological Conditions, Anatomical, Hernia, Abdominal
Interventions: Integra® Gentrix® Surgical Matrix; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Hiatal Hernia Large, Reflux, Gastroesophageal
Interventions: Hiatal Hernia Repair with Platelet Rich Plasma, Hiatal Hernia Repair without Platelet Rich Plasma; Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Newport Beach, California

Conditions: Incisional Hernia, Ventral Hernia
Interventions: NG-TSM; Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 6
States / cities: Jefferson City, Missouri • St Louis, Missouri • The Bronx, New York + 3 more

Conditions: Sepsis, Congenital Diaphragmatic Hernia, Neonatal Cardiopulmonary Failure
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Up to 2 Months
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Salt Lake City, Utah

Search by objective public record fields.

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial

North American Fetal Therapy Network for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia

Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy

Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair

Fetal Tracheal Balloon Study in Diaphragmatic Hernia

Cryoneurolysis for Abdominal Wall Relaxation Prior to Ventral Hernia Repair

Preoperative BOTOX® Injection for Large Ventral Hernia Repair

Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management

The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction

The Economic Impact of Four Varieties of Mesh Inguinal Hernia Repair- a Double-Blinded, Prospective, Randomized Trial

Comparison of Two Different Pain Management Techniques in Pediatric Patients Undergoing a Hernia Repair

Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh

Complex Ventral Hernia Repair Using Biologic or Synthetic Mesh

Fetoscopic Endoluminal Tracheal Occlusion

Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study

Compassionate Use of Omegaven in Children

Laryngeal Mask Airway in Laparoscopic Hernia Repair

Genetic Analysis of Congenital Diaphragmatic Disorders

Efficacy Study to Evaluate Laparoscopic Fascial Closure Device

T-GENVIH-003 LTFU (Long Term Follow Up) Study

Platelet Rich Plasma in Hiatal Hernia Repair

Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair

Inflammatory Cytokine Quantification in Infants